Skip to content

DocGo DCGO Equity method investment, impairment

Equity method investment, impairment at other companies

DocGo logo
DocGoDCGO
$0-100%
Seacor Marine Holdings Inc. logo
Seacor Marine Holdings Inc.SMHI
$0
Bel Fuse logo
Bel FuseBELFB
$13.1M
Nexstar Media Group, Inc. logo
Nexstar Media Group, Inc.NXST
$95.25M
Lakeland Industries logo
Lakeland IndustriesLAKE
$0-100%
Alset Inc. logo
Alset Inc.AEI
-$7.52M

Other financials

Income statement

See full
Revenue$75.6M-21.3%
Gross profit-$407.9M-25.6%
Operating income-$18.7M-33.7%
Net income-$14.8M-57.0%
EPS (diluted)-$0.15-66.7%

Balance sheet

See full
Cash & equivalents$46.8M-54.6%
Total debt$28.5M-7.6%
Total equity$132.3M-57.2%
Total assets$209.2M-51.4%

Cash flow

See full
Operating cash flow-$4.7M-151%
CapEx$430.3K-58.2%
Free cash flow-$5.1M-162%

Valuation

See full
Market cap$50.98M-67.2%
Enterprise value$32.67M-59.1%
P/S0.2×-0.2×

Profitability

See full
Operating margin-60.6%
Net margin-62.2%
FCF margin14.6%+8.1pp

Returns & leverage

See full
Return on equity-85%
Debt / equity0.2×+0.1×
Current ratio1.8×-0.7×

Where this comes from

Reported directly by DocGo in its filing.

Tagged under the XBRL concept us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment.

The official record: DocGo’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about DocGo's equity method investment, impairment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DocGo's equity method investment, impairment?
DocGo (DCGO) reported equity method investment, impairment of $0 in Q1 2026.
How has DocGo's equity method investment, impairment changed year-over-year?
DocGo's equity method investment, impairment decreased by 100.0% year-over-year, from $40.7K to $0.
What does equity method investment, impairment mean?
Reflects the recognition of an other-than-temporary decline in the value of investments accounted for under the equity method. This charge signals that the underlying value of an associate or joint venture has diminished significantly, requiring a write-down of the investment's book value.